Clint Allen
National Institutes of Health(US)National Cancer Institute(US)Center for Cancer Research(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Immune cells in cancer, interferon and immune responses
Most-Cited Works
- → Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models(2019)266 cited
- → Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS(2021)229 cited
- → Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy(2019)228 cited
- → Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ(2017)209 cited
- → Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma(2017)183 cited
- → Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy(2019)173 cited